Clinical Trial Update: Esketamine With or Without Integration Therapy for Treatment-Resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating esketamine with or without integration therapy for treatment-resistant depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: University of Puerto Rico | Conditions: Treatment-resistant Depression (TRD) | Phase 4 | Status: RECRUITING